Skip to main content
. 2019 Aug 9;98(32):e16490. doi: 10.1097/MD.0000000000016490

Figure 1.

Figure 1

The CT scan shows a lesion tumors under envelop of liver were gradually exacerbated after 2 and 4 courses of nivolumab plus S1 respectively (from February to July), and shrinking after nivolumab combined with SOX (from August to November). CT = computed tomography.